Product correctly added to cart.

discount label
RAD 140
View 3D

Biosynth logo

RAD 140

CAS: 1182367-47-0

Ref. 3D-FR159306

1g
266.00 €
2g
386.00 €
500mg
172.00 €
Estimated delivery in United States, on Friday 27 Dec 2024

Product Information

Name:
RAD 140
Controlled Product
Synonyms:
  • 2-Chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methyl-benzonitrile
  • Vosilasarm
  • 2-Chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile
  • Benzonitrile, 2-chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methyl-
  • Testolone
Description:

RAD 140 is a CDK4/6 inhibitor that has been shown to inhibit cell proliferation in vitro and in vivo. It has also been shown to be effective against prostate cancer cells, as well as other cancers. RAD 140 binds to the epidermal growth factor receptor (EGFR), inhibiting its function. RAD 140 is a diagnostic agent, which can be used to detect the presence of CDK4/6 inhibitors in urine samples. The detection time for RAD 140 is longer than that of other CDK4/6 inhibitors, such as Palbociclib.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
393.83 g/mol
Formula:
C20H16ClN5O2
Purity:
Min. 95 Area-%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FR159306 RAD 140

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".